0001144204-11-021523.txt : 20110412 0001144204-11-021523.hdr.sgml : 20110412 20110412154815 ACCESSION NUMBER: 0001144204-11-021523 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110412 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110412 DATE AS OF CHANGE: 20110412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-72097 FILM NUMBER: 11754940 BUSINESS ADDRESS: STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201 STREET 2: SUITE 201 CITY: NAPLES STATE: FL ZIP: 34108 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201 STREET 2: SUITE 201 CITY: NAPLES STATE: FL ZIP: 34108 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 8-K 1 v218341_8-k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
April 12, 2011

NEOGENOMICS, INC.
(Exact name of registrant as specified in its charter)

Nevada
333-72097
74-2897368
(State or other jurisdiction of
(Commission File Number)
(I.R.S. Employer
incorporation)
  
Identification No.)
     
12701 Commonwealth Drive, Suite 9, Fort Myers, Florida
 (Address of principal executive offices)
33913
 (Zip Code)
   
   
(239) 768-0600
 (Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
□
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
□
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
□
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 9.01.             Financial Statements and Exhibits.
 
(a)           Not applicable
 
(b)           Not applicable
 
(c)           Not applicable
 
(d)           Exhibits.
 
       23.1 
Consent of Kingery & Crouse, P.A.


 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  NEOGENOMICS, INC.  
       
 
By:
/s/ George Cardoza  
    George Cardoza  
    Chief Financial Officer   
       

 
Date: April 12, 2011
 
 
 
 
 
Exhibit Index
 
Exhibit No.
  
Description
     
23.1
  
Consent of Kingery & Crouse, P.A.
 

 
 
 
 
EX-23.1 2 v218341_ex23-1.htm
EXHIBIT 23.1


Consent of Independent Registered Public Accounting Firm


To the Board of Directors of NeoGenomics, Inc.

We have issued our report dated March 26, 2010, accompanying the consolidated financial statements included in the Annual Report of NeoGenomics, Inc. on Form 10-K for the year ended December 31, 2009 and our report dated February 23, 2011, accompanying the consolidated financial statements included in the Annual Report of NeoGenomics, Inc. on Form 10-K for the year ended December 31, 2010.

We hereby consent to the incorporation by reference of said reports in the Registration Statement of NeoGenomics, Inc. on Form S-8 (File No. 333-139484), the Registration Statement of NeoGenomics, Inc. on Form S-8 (File No. 333-125994) and the Registration Statement of NeoGenomics, Inc. on Form S-8 (File No. 333-159749).


/s/ Kingery & Crouse,  P.A.

Kingery & Crouse, P.A.
Certified Public Accountants

Tampa, Florida
April 12, 2011